Treatments

Covid-19 antibody levels jump among elderly after autumn booster The 35-49 age group now has the lowest estimated level of antibodies. Ian Jones, PA AOL

...

Some 96.3% of people aged 80 and over in England were likely to have antibodies at the start of December 2022, up from 89.2% in early September.

For 75 to 79-year-olds, the proportion stands at 95.8%, up from 87.4%.   ...

The figures are “likely a result of the vaccination booster campaign”, according to the Office for National Statistics (ONS), which has published the data.

...

New Utah study affirms COVID vaccine is safe for kids The study, co-authored by a doctor at Primary Children's Hospital, looked at 185 kids who suffered from MIS-C. Erin Alberty Axios

A new Utah-led study shows the COVID-19 vaccine didn't trigger dangerous responses in children who previously had a severe reaction to the virus itself.

...

Paying people to take COVID vaccine worked well, study finds Paying people to take a first COVID-19 vaccine dose didn't lower the likelihood of seeking the second or third dose or of other positive health behaviors. CIDRAP

A study finds that paying people to take a first dose of a COVID-19 vaccine didn't lower the likelihood of seeking the second or third dose or of other positive health behaviors and didn't erode morals, sense of civic duty, or feelings of self-determination.

Mpox has faded in the US. Who deserves the credit? NEW YORK (AP) — Less than six months ago, mpox was an exploding health crisis. What had been an obscure disease from Africa was ripping through European and U.S. gay communities. Precious doses of an unproven vaccine were in short supply. AP NEWS

...

So who deserves the credit? It’s an unsettled question, but experts cite a combination of factors.